<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00495222</url>
  </required_header>
  <id_info>
    <org_study_id>CI-06-0005</org_study_id>
    <nct_id>NCT00495222</nct_id>
  </id_info>
  <brief_title>Endoscopic Suturing System for Tissue Apposition</brief_title>
  <official_title>Evaluation of an Endoscopic Suturing System for Tissue Apposition</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ethicon Endo-Surgery</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ethicon Endo-Surgery</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this feasibility trial is to evaluate the Ethicon Endo-Surgery Endoscopic
      Suturing System (ESS) for tissue apposition and reduction of the size of a dilated GJ
      anastomosis in subjects who are regaining weight after successful weight loss following
      gastric bypass. Post-procedure weight will be followed to assess whether weight loss is
      resumed.

      The ESS is an FDA-cleared (510(k)) sterile, single-use, disposable suturing system indicated
      for endoscopic placement of suture(s) and approximation of soft tissues. It is designed to
      facilitate endoscopic gastrointestinal procedures.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2007</start_date>
  <completion_date type="Actual">June 2008</completion_date>
  <primary_completion_date type="Actual">April 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Knotting Elements Placed</measure>
    <time_frame>intra-operative</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">9</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Tissue plication</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The Endoscopic Suturing System (ESS) is used for tissue apposition and reduction of the size of a dilated GJ anastomosis in subjects who are regaining weight after successful weight loss following gastric bypass</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Tissue plication</intervention_name>
    <description>Tissue apposition and plication of a dilated GJ anastomosis with the Endoscopic Suturing System</description>
    <arm_group_label>Tissue plication</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Endoscopic Suturing System</intervention_name>
    <description>Tissue plication of dilated GJ stoma</description>
    <arm_group_label>Tissue plication</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Tissue Plication</intervention_name>
    <description>Tissue plication for GJ stoma reduction</description>
    <arm_group_label>Tissue plication</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

        Subjects must fulfill the following criteria to be entered in this study:

          -  Review and sign informed consent;

          -  Between 21 and 65 years of age (inclusive) at time of trial enrollment;

          -  Documented Roux-en-Y Gastric Bypass (RYGB) surgery date

          -  Documented baseline weight at the time of RYGB procedure;

          -  &gt; 12 months post RYGB);

          -  Body mass Index (BMI) &gt; 30 and at least 20 pounds in excess of post-RYGB weight nadir;

          -  Patients initially achieved at least 50% excess weight loss (EWL) post RYGB;

          -  Visible anastomotic junction (between gastric pouch and the Roux-limb);

          -  Stoma size at screening &gt; 15mm; and

          -  Negative serum pregnancy test for women of childbearing potential.

        Exclusion Criteria

        Subjects will be excluded from the trial for any of the following:

          -  Documented history of esophageal pathology (e.g., esophageal varices, Barrett's
             Esophagus);

          -  American Anesthesia Association (ASA) Class IV or V and/or any contraindications to
             monitored anesthesia;

          -  Documented history of GJ anastomosis stricture (within 6 months);

          -  Documented history of previous RYGB revision;

          -  Presence or documented presence of gastric/duodenal ulcers;

          -  Presence of sepsis;

          -  Medical or physical endoscopic contraindications, including esophageal varices or
             bleeding, laryngeal perforation, trauma to pharynx, aspiration pneumonia, acute
             peritonitis, and other conditions where general endoscopic techniques and/or placement
             of overtube are contraindicated;

          -  Chronic Non-Steroidal Anti-Inflammatory Drug (NSAID) use (subjects taking a single
             aspirin tablet per day for cardioprotection are considered acceptable);

          -  Uncontrolled diabetes;

          -  Physical or psychological condition which would impair trial participation per
             investigator discretion;

          -  Binge-eating or similar eating disorders;

          -  Unable or unwilling to attend follow-up visits and examinations;

          -  Concurrent surgical procedure (intra-operative exclusion during ESS procedure);

          -  Participation in any other investigational device or drug trial within 30 days prior
             to enrollment; or

          -  Any condition, which precludes compliance with the trial.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alfonso Torquati, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 29, 2007</study_first_submitted>
  <study_first_submitted_qc>July 2, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 3, 2007</study_first_posted>
  <results_first_submitted>April 21, 2009</results_first_submitted>
  <results_first_submitted_qc>August 10, 2009</results_first_submitted_qc>
  <results_first_posted type="Estimate">August 11, 2009</results_first_posted>
  <last_update_submitted>September 8, 2009</last_update_submitted>
  <last_update_submitted_qc>September 8, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 10, 2009</last_update_posted>
  <responsible_party>
    <name_title>Susan Knippenberg</name_title>
    <organization>Ethicon Endo-Surgery</organization>
  </responsible_party>
  <keyword>gastrojejunostomy</keyword>
  <keyword>stoma</keyword>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Tissue Plication</title>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Tissue Plication</title>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="9"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35.5" spread="5.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Knotting Elements Placed</title>
        <description>completion of plication (1-3 knotting elements placed per procedure)</description>
        <time_frame>intra-operative</time_frame>
        <population>Intent to Treat</population>
        <group_list>
          <group group_id="O1">
            <title>Tissue Plication</title>
          </group>
        </group_list>
        <measure>
          <title>Knotting Elements Placed</title>
          <description>completion of plication (1-3 knotting elements placed per procedure)</description>
          <population>Intent to Treat</population>
          <units>elements</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Susan Knippenberg</name_or_title>
      <organization>Ethicon Endo-Surgery</organization>
      <phone>513 337-3452</phone>
      <email>sknippen@its.jnj.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

